The effect of fondaparinux versus enoxaparin in the survival of a congested skin flap in a rabbit model

Thomas L. Chung, Luther H. Holton, Ronald P. Silverman

Research output: Contribution to journalArticle

Abstract

Background: The purpose of this study was to evaluate the effects of fondaparinux, a selective antithrombin III agonist, in comparison to the low-molecular-weight heparin enoxaparin in the survival of a congested skin flap. Materials and Methods: Eighteen axial-pattern auricular flaps were performed on rabbits using a well-described congested flap model. Animals were randomized into 2 treatment groups, enoxaparin (n = 6) and fondaparinux (n = 6), and a control group (n = 6) that received no treatment. Skin flap survival area was measured post-operatively at 7 and 14 days. Results: The groups that received fondaparinux and enoxaparin had similar mean flap survival areas and were not statistically different. However, both treatment groups significantly increased flap survival compared with controls (P <0.014). Conclusions: Fondaparinux, like enoxaparin, significantly improves survival of congested flaps in rabbits. Its use instead of enoxaparin may be warranted, given that it eliminates the risk of heparin-induced thrombocytopenia. Further study in humans is warranted.

Original languageEnglish (US)
Pages (from-to)312-315
Number of pages4
JournalAnnals of Plastic Surgery
Volume56
Issue number3
DOIs
StatePublished - Mar 2006
Externally publishedYes

Keywords

  • Enoxaparin
  • Flap congestion
  • Flap survival
  • Fondaparinux

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'The effect of fondaparinux versus enoxaparin in the survival of a congested skin flap in a rabbit model'. Together they form a unique fingerprint.

Cite this